相关实验视频
Updated: May 3, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.0K
里德尔甲状腺炎和具有乳头状核特征的非侵入性毛囊新生体:一种独特的共存和诊断挑战
Monia Ghammam1, Jihène Houas1, Taissir Ben Arfi1
1ENT Department and Cervical Surgery, Farhat Hached Hospital, University of Sousse, Tunisia.
Ear, nose, & throat journal
|April 2, 2025
概括
本病例报告详细介绍了一例罕见的里德尔甲状腺炎与具有乳头状核特征 (NIFTP) 的非侵入性卵泡瘤共存. 这项研究强调了诊断挑战和管理这种独特的表现,最初被误认为是甲状腺.
科学领域:
- 内分泌学 在内分泌学.
- 病理学 病理学 病理学
- 手术瘤学手术瘤学
背景情况:
- 里德尔甲状腺炎是一种罕见的,甲状腺纤维化的炎症状况,通常在临床上模仿恶性瘤.
- 里德尔甲状腺炎和具有乳头状核特征 (NIFTP) 的非侵入性卵泡瘤同时发生是非常罕见的,以前没有报告过.
- 甲状腺疹可能会出现类似的症状,使初始诊断复杂化.
研究的目的:
- 报告第一个同时出现里德尔甲状腺炎和NIFTP的记录病例.
- 讨论这种罕见的共存的诊断挑战和非典型表现.
- 概述用于这种独特的临床场景的管理策略.
主要方法:
- 一个63岁的男性患有急性宫质量,发烧和消化不良的病例介绍.
- 诊断工作包括成像 (CT扫描) 和甲状腺切除术后甲状腺组织病理学检查.
- 术后评估包括对全身纤维化干扰和并发症的评估.
主要成果:
- 组织病理学证实了里德尔的甲状腺炎与甲状腺外延伸和潜在的NIFTP.
- 患者的初始呈现模仿了甲状腺,需要在手术前接受抗生素治疗.
- 手术后的并发症包括左声带麻痺和初级副甲状腺功能障碍;全身纤维化被排除在外.
结论:
- 里德尔甲状腺炎和NIFTP的共存带来了重大的诊断和管理挑战.
- 早期识别和适当的手术干预对于最佳的患者结果至关重要.
- 这一案例强调了在复杂的甲状腺病理中进行彻底的组织病理学评估的重要性.
相关概念视频
The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32

